ADT
50
5
HST
34
2
DGX
57
3
PEG
53
3
MPC
44
8
AMT
59
13
GWW
41
2
CCI
54
15
VTR
57
2
IVZ
39
7
PNC
55
3
V
46
2
KLAC
63
6
DAL
28
6
NUE
47
3
CRM
39
5
SIG
54
2
AFL
59
4
XOM
60
4
ADI
54
3
ADT
50
5
HST
34
2
DGX
57
3
PEG
53
3
MPC
44
8
AMT
59
13
GWW
41
2
CCI
54
15
VTR
57
2
IVZ
39
7
PNC
55
3
V
46
2
KLAC
63
6
DAL
28
6
NUE
47
3
CRM
39
5
SIG
54
2
AFL
59
4
XOM
60
4
ADI
54
3
Financhill
Back

ACADIA Pharmaceuticals 10K Form

Buy
55

ACAD
ACADIA Pharmaceuticals

Last Price:
$17.49
Seasonality Move:
19.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q ACAD/ACADIA Pharmaceuticals Quarterly
2024-02-28 10K ACAD/ACADIA Pharmaceuticals Annual
2023-11-03 10Q ACAD/ACADIA Pharmaceuticals Quarterly
2023-08-03 10Q ACAD/ACADIA Pharmaceuticals Quarterly
2023-05-08 10Q ACAD/ACADIA Pharmaceuticals Quarterly
2023-02-28 10K ACAD/ACADIA Pharmaceuticals Annual

Receive ACAD News And Ratings

See the #1 stock for the next 7 days that we like better than ACAD

ACAD Financial Statistics

Sales & Book Value

Annual Sales: $957.8M
Cash Flow: $39.9M
Price / Cash Flow: 18.54
Annual Sales: $4.40
Price / Book: 3.98

Profitability

EPS (TTM): 1.36000
Net Income (TTM): $226.5M
Gross Margin: $876M
Return on Equity: 41.59%
Return on Assets: 24.18%

ACADIA Pharmaceuticals Earnings Forecast

Key ACADIA Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 20 years for ACAD is 91.46%.
  • The Selling, General & Administrative Expenses for ACAD have been equal to 50.99% of Gross Profit Margin.
  • The Research & Development expenses have been 31.66% of Revenue.
  • The Net Earning history of ACAD is 23.64% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 12 years.

ACADIA Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ACAD
CUSIP: 004225
Website: acadia.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.38
Quick Ratio: 2.18

Price-to-Earnings

Trailing P/E Ratio: 12.87
Forward P/E Ratio: 17.51

ACAD Technical Analysis vs Fundamental Analysis

Buy
55
ACADIA Pharmaceuticals (ACAD) is a Buy

Is ACADIA Pharmaceuticals a Buy or a Sell?